Ex Parte NILSEN et al - Page 2




              Appeal No. 2003-1792                                                                                     
              Application No. 09/434,598                                                                               
                     wherein, after introduction of the nucleic acid molecules, each cell comprises the                
              first reporter gene, a second reporter gene, and a targeting gene, wherein the first                     
              reporter gene encodes a fusion protein comprising a protein of interest and a first                      
              reporter protein, wherein the second reporter gene encodes a second reporter protein,                    
              wherein the protein of interest is encoded by the RNA of interest, wherein the targeting                 
              gene encodes an affector RNA molecule comprising a targeting sequence, wherein                           
              each nucleic acid molecule in the set is the same except for the encoded affector RNA                    
              molecule, wherein (1) the affector RNA molecule encoded in each nucleic acid                             
              molecule in the set is targeted to a different site on the RNA molecule of interest or to a              
              different site in the portion of the first reporter gene encoding the RNA molecule of                    
              interest, or (2) the targeting sequence of the affector RNA molecule in each nucleic acid                
              molecule is degenerate or partially degenerate,                                                          
                     (b) identifying those cells from step (a) that both express the second reporter                   
              protein and exhibit reduced expression of the first reporter protein, and                                
                     (c) identifying the affector RNA molecules encoded by the nucleic acid molecules                  
              present in the cells that both express the second reporter protein that exhibit reduced                  
              expression of the first reporter protein.                                                                
                     The prior art references cited by the examiner are:                                               
              George et al (George)1                    WO 96/21731                       July 18, 1996                
              Milligan et al. (Milligan),”Current Concepts in Antisense Drug Design,” J. of Med.                       
              Chem., Vol. 36, No. 14, pp. 1923-1937 (1993)                                                             
              Grounds of Rejection                                                                                     
                     Claims 34, 35 and 37 stand rejected under 35 U.S.C.  §102(b), as anticipated by                   
              George.                                                                                                  
                     Claim 36 stands rejected under 35 U.S.C. §103(a), as obvious over George in                       
              view of Milligan.                                                                                        
                     We affirm these rejections.                                                                       
              Claim Grouping                                                                                           

                     1  Throughout the prosecution history, the examiner mistakenly refers to this publication as Shaji,
              et al.  We refer to this international publication by its appropriate first author, as “George.”         
                                                          2                                                            



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007